SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 137 filers reported holding SYNDAX PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $365,000 | -40.1% | 20,981 | -24.6% | 0.00% | – |
| Q4 2021 | $609,000 | +19.4% | 27,826 | +4.2% | 0.00% | – |
| Q3 2021 | $510,000 | -5.0% | 26,700 | -14.7% | 0.00% | – |
| Q2 2021 | $537,000 | -24.2% | 31,289 | -1.2% | 0.00% | – |
| Q1 2021 | $708,000 | +51.9% | 31,669 | +51.2% | 0.00% | – |
| Q4 2020 | $466,000 | +79.9% | 20,946 | +19.2% | 0.00% | – |
| Q3 2020 | $259,000 | -19.3% | 17,566 | -19.0% | 0.00% | – |
| Q2 2020 | $321,000 | +66.3% | 21,686 | +23.1% | 0.00% | – |
| Q1 2020 | $193,000 | +11.6% | 17,621 | -10.7% | 0.00% | – |
| Q4 2019 | $173,000 | +16.9% | 19,727 | -0.5% | 0.00% | – |
| Q3 2019 | $148,000 | -13.5% | 19,826 | +8.3% | 0.00% | – |
| Q2 2019 | $171,000 | +147.8% | 18,314 | +39.2% | 0.00% | – |
| Q1 2019 | $69,000 | -82.8% | 13,152 | -61.7% | 0.00% | – |
| Q3 2017 | $401,000 | -21.5% | 34,310 | -6.2% | 0.00% | -100.0% |
| Q2 2017 | $511,000 | +64.3% | 36,565 | +61.4% | 0.00% | – |
| Q1 2017 | $311,000 | +87.3% | 22,654 | -2.0% | 0.00% | – |
| Q4 2016 | $166,000 | -53.6% | 23,127 | -2.0% | 0.00% | -100.0% |
| Q3 2016 | $358,000 | +56.3% | 23,591 | +1.3% | 0.00% | – |
| Q2 2016 | $229,000 | – | 23,293 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,600,000 | $52,272,000 | 8.55% |
| Foresite Capital Management IV, LLC | 875,000 | $12,705,000 | 7.06% |
| Aisling Capital Management LP | 1,025,000 | $14,883,000 | 6.13% |
| Saturn V Capital Management LP | 807,969 | $11,731,710 | 4.91% |
| Eversept Partners, LP | 2,596,245 | $37,697,477 | 3.19% |
| ACUTA CAPITAL PARTNERS, LLC | 297,035 | $4,312,948 | 2.89% |
| Paradigm Biocapital Advisors LP | 2,390,077 | $34,703,918 | 2.36% |
| DAFNA Capital Management LLC | 458,373 | $6,655,576 | 2.07% |
| SPHERA FUNDS MANAGEMENT LTD. | 773,061 | $11,224,846 | 2.04% |
| PFM Health Sciences, LP | 2,715,235 | $39,425,212 | 1.86% |